Clonogenic assays improve determination of variant allele frequency of driver mutations in myeloproliferative neoplasms

Molecular diagnostics moves more into focus as technology advances. In patients with myeloproliferative neoplasms (MPN), identification and monitoring of the driver mutations have become an integral part of diagnosis and monitoring of the disease. In some patients, none of the known driver mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalmer, Milena, Pannen, Kristina, Lemanzyk, Rebecca, Wirths, Chiara, Baumeister, Julian, Maurer, Angela, Kricheldorf, Kim, Schifflers, Joelle, Gezer, Deniz, Isfort, Susanne, Brümmendorf, Tim H., Koschmieder, Steffen, Chatain, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646600/
https://www.ncbi.nlm.nih.gov/pubmed/36269400
http://dx.doi.org/10.1007/s00277-022-05000-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646600/
https://www.ncbi.nlm.nih.gov/pubmed/36269400
http://dx.doi.org/10.1007/s00277-022-05000-9

Ejemplares similares